Article: Morning Alert for Avanir Pharmaceuticals.

M2 PRESSWIRE-18 April 2007-Biotech News: Morning Alert for Avanir Pharmaceuticals(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:18042007

Morning Alert for Avanir Pharmaceuticals (NASDAQ:AVNR)

Avanir Pharmaceuticals, together with its subsidiaries, engages in the development, acquisition, and commercialization of therapeutic products for the treatment of chronic human diseases. Its product candidates serve various therapeutic markets, including the central nervous system, cardiovascular disorders, inflammatory, and infectious diseases. The company markets FazaClo, an orally-disintegrating formulation of clozapine for the treatment of resistant ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!